The Aplio i-series features innovative technology, outstanding image quality, intuitive ergonomics and advanced features for high diagnostic confidence and improved patient care. Giving healthcare providers the performance improvements needed to expand the clinical utility of ultrasound to meet the current and future challenges of the healthcare system, Toshiba Medical has introduced the ultra-premium Aplio i-series ultrasound platform. The Aplio i-series’ powerful performance helps increase diagnostic confidence substantially and offers a more cost-effective, less invasive and safe solution in imaging diagnostics and intervention. The Aplio i-series is a new-generation, ultra-high performance, scalable platform. Specifically the Aplio i700 and Aplio i800 are perfectly suited to radiology and shared service departments with a high patient throughput. Both systems are based on iPerformance technologies that deliver extreme processing power allowing sonographers to see more clinical detail faster and easier. A new beamforming technology – iBeam – optimizes imaging efficiency with enhanced penetration, as well as increased spatial and contrast resolution, while minimizing artifacts and clutter. The Aplio i800 offers advanced clinical applications, including Toshiba Medical’s exclusive intelligent Dynamic Micro Slice (iDMS) matrix probe technology. An ultra-high frequency transducer operating at up to 24 MHz opens a new horizon for clinicians to image anatomy and perfusion of superficial structures in the sub-millimeter range. Based on the iSense design concept, the Aplio i-series provides intuitive ergonomics to boost productivity in the daily routine and for complex exams. The systems offer an intuitive user interface, which visually guides the clinician through the exam to simplify system operation, while improving workflow efficiency. To make ultrasound exams easier and faster, the systems feature tablet-style touch screens and real-time Quick Scan, which optimizes the image quality automatically and instantaneously.
Read more

The Acuson NX3 and Acuson NX3 Elite offer a simple, intuitive interface combined with innovative imaging solutions for examinations primarily in general medicine, obstetrics/ gynecology, pediatrics and neurology. The customizable control panel and touch screen combined with Siemens innovative workflow innovations make it possible to perform certain routine anatomical measurements up to 76 percent faster than traditional solutions. The Acuson NX3 systems are equipped with a LED monitor (21.5′) and a touch screen (10.4′) which are among the largest in their class. To make daily routine examinations easier, the Acuson NX3 systems feature advanced ultrasound innovations, including Clarify vascular enhancement technology which provides multiple levels of clarification to optimize tissue contrast resolution and definition of both tissue and vessel walls. Higher image resolution is enabled with the 16 MHz transducer, which is especially suitable for breast and musculoskeletal imaging.
Read more

A new connectivity package for EKF’s Quo-Test and Quo-Lab HbA1c analysers enables secure bi-directional communication between these POC analysers and a multitude of central data management systems. Using the industry recognized POCT1-A2 communication protocol, EKF’s connectivity solution unlocks a host of new features aimed at improving security and quality control (QC) for diabetic HbA1c testing. The new connectivity package includes a proprietary connector interface box, cables and a software upgrade. This enables EKF’s HbA1c analysers to automatically transmit patient data to the majority of Lab Information Management Systems (LIMS) or Hospital Information Systems (HIS). Traceability and results recall speed are improved by use of patient ID and increased demographic data (such as family name and date of birth). These can now be recorded through either selecting from a pre-approved list or via the barcode scanner and keyboard. Also ensuring the integrity of results generated at the POC, security and QC are enhanced on Quo-Lab and Quo-Test through user ID and QC lockout functions which are included in the connectivity package. By restricting access to trained users only, the lockout functions minimize the chances of user error and adhere to security protocols in many institutions. Furthermore, unauthorized users will be prevented from accessing patient information. Multiple user-defined QC lockout options are also available to POCT coordinators in order to enforce regular testing of QC materials and ensure compliance. In addition to ensuring the reliability of results, the new conectivity package also allows the clinician to add commentary to any test result, further enhancing the monitoring and management of diabetes in a point-of-care setting.
Read more

Siemens has refined its Syngo Dynamics cardiovascular information system (CVIS) to not only help diagnose cardiovascular diseases but also to reduce the administrative load on medical staff and provide the best possible support in outcome-focused management decisions. The main focuses for improvement are on reading and reporting capabilities as well as interoperability and integration into other systems, such as the electronic health record (EHR) system. Data exchange between disparate systems makes improved efficiency and care outcomes possible. This interoperability gives various departments within a hospital
Read more